Compliance Considerations in Pharmaceutical Product Development Compliance Considerations in Pharmaceutical Product Development John C. (Jack) Garvey,
AlpArray Magnetotelluric MT Group at the GFZ 12E swath meeting, 18. Juli, 11:00 - 17:00.